Perflenapent
- Generic Name
- Perflenapent
- Drug Type
- Small Molecule
- Chemical Formula
- C5F12
- CAS Number
- 678-26-2
- Unique Ingredient Identifier
- 483AU1Y5CZ
- Background
Dodecafluoropentane is also known as perfluoropentane or perflenapent.
A Dose Escalation Study of NanO2 in Patients with Mild Respiratory Distress
Phase 1
Not yet recruiting
- Conditions
- Mild Respiratory Distress
- Interventions
- First Posted Date
- 2024-10-26
- Last Posted Date
- 2025-01-29
- Lead Sponsor
- NuvOx LLC
- Target Recruit Count
- 18
- Registration Number
- NCT06658535
19F MRI to Evaluate Regional Ventilation in Healthy Subjects and Subjects With Cystic Fibrosis
- First Posted Date
- 2018-04-05
- Last Posted Date
- 2019-10-04
- Lead Sponsor
- University of North Carolina, Chapel Hill
- Target Recruit Count
- 42
- Registration Number
- NCT03489590
- Locations
- 🇺🇸
The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
Comparison of 129Xe MRI With 19F MRI in CF Lung Disease
- First Posted Date
- 2018-03-29
- Last Posted Date
- 2021-01-25
- Lead Sponsor
- University of North Carolina, Chapel Hill
- Target Recruit Count
- 11
- Registration Number
- NCT03482960
- Locations
- 🇺🇸
The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
A Phase Ib Study of NVX-508 in Sickle Cell Disease
- First Posted Date
- 2017-01-06
- Last Posted Date
- 2018-07-16
- Lead Sponsor
- Amma Owusu-Ansah, MD
- Registration Number
- NCT03013426
Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders
Early Phase 1
Terminated
- Conditions
- AsthmaLung TransplantCystic FibrosisEmphysemaPulmonary EmbolismPulmonary FibrosisObstructive Sleep ApneaLung ResectionPulmonary HypertensionCold Virus
- Interventions
- Drug: HP 3HeDrug: HP 129XeDrug: SF6Device: 129Xe Small and Large Human Lung CoilDevice: 3He Human Lung CoilDevice: PFP and SF6 Human Lung Coil
- First Posted Date
- 2016-04-22
- Last Posted Date
- 2024-10-11
- Lead Sponsor
- Thunder Bay Regional Health Research Institute
- Target Recruit Count
- 10
- Registration Number
- NCT02748798
- Locations
- 🇨🇦
Thunder Bay Regional RI, Thunder Bay, Ontario, Canada
The Effects of NVX-108 as a Radiation Sensitizer in Glioblastoma
- First Posted Date
- 2014-07-14
- Last Posted Date
- 2019-02-28
- Lead Sponsor
- NuvOx LLC
- Target Recruit Count
- 11
- Registration Number
- NCT02189109
- Locations
- 🇦🇺
Flinders Medical Centre, Adelaide, South Australia, Australia
🇦🇺St. Vincents Hospital Sydney, Darlinghurst, New South Wales, Australia
🇦🇺Epworth Center, Melbourne, Victoria, Australia
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath